Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DSGX | DESCARTES SYSTEMS GROUP INC | NASDAQ | Software - Application | $6.19B | $71.98 | 4.17% | $305.19M | 37.69x | 0.17 | Canada | ||
| ENOV | ENOVIS CORP | NYSE | Specialty Industrial Machinery | $1.34B | $23.39 | -5.84% | -$832.95M | -1.13x | 1.57 | United States | ||
| BMA | MACRO BANK INC | NYSE | Banks - Regional | $4.49B | $70.16 | -6.10% | $445.30M | 15.42x | 2.58 | Argentina | ||
| CCCC | C4 THERAPEUTICS INC | NASDAQ | Biotechnology | $268.34M | $2.75 | -8.03% | -$96.48M | -2.17x | 0.40 | United States | ||
| TYRA | TYRA BIOSCIENCES INC | NASDAQ | Biotechnology | $1.94B | $36.00 | -1.48% | -$119.40M | -17.91x | 0.09 | United States | ||
| EVTL | VERTICAL AEROSPACE LTD | NYSE | Aerospace & Defense | $381.19M | $3.82 | -4.98% | $137.54M | -0.09x | -2.29 | United Kingdom | ||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | NASDAQ | Capital Markets | $505.62M | $2.08 | -2.35% | $74.88M | -8.32x | 0.12 | Canada | ||
| IPHA | INNATE PHARMA SA | NASDAQ | Biotechnology | $130.41M | $1.50 | -3.23% | -$46.80M | -2.32x | 17.07 | France | ||
| BIOA | BIOAGE LABS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | $712.98M | $19.89 | -0.92% | -$74.56M | 1.46x | 0.10 | United States | ||
| FBIZ | FIRST BUSINESS FINANCIAL SERVICES INC | NASDAQ | Banks - Regional | $437.91M | $52.49 | 0.19% | $64.23M | 8.84x | 9.99 | United States | ||
| CLFD | CLEARFIELD INC | NASDAQ | Communication Equipment | $392.63M | $28.69 | -2.45% | $1.82M | -58.55x | 0.07 | United States | ||
| FLR | FLUOR CORP | NYSE | Engineering & Construction | $6.37B | $43.48 | -2.51% | $20.00M | -140.26x | 1.53 | United States | ||
| WALD | WALDENCAST PLC | NASDAQ | Software - Application | $180.20M | $1.46 | -3.95% | -$126.07M | -0.81x | 0.45 | United States | ||
| NEXN | NEXXEN INTERNATIONAL LTD | NASDAQ | Advertising Agencies | $211.77M | $7.53 | 0.47% | $102.58M | 8.96x | 0.59 | Israel | ||
| VIR | VIR BIOTECHNOLOGY INC | NASDAQ | Biotechnology | $1.32B | $9.48 | -3.46% | -$421.11M | -3.00x | 0.31 | United States | ||
| AMBA | AMBARELLA INC | NASDAQ | Semiconductor Equipment & Materials | $2.26B | $52.42 | -2.93% | -$53.87M | -27.88x | 0.27 | United States | ||
| ONC | BEONE MEDICINES LTD | NASDAQ | Biotechnology | $31.68B | $285.30 | -4.55% | $616.77M | 1,426.50x | 0.88 | Cayman Islands | ||
| GLUE | MONTE ROSA THERAPEUTICS INC | NASDAQ | Biotechnology | $1.04B | $16.04 | -5.98% | $30.28M | 50.13x | 0.87 | United States | ||
| STKL | SUNOPTA INC | NASDAQ | Packaged Foods | $762.23M | $6.44 | -0.31% | $77.07M | 49.54x | 2.98 | Canada | ||
| ENTA | ENANTA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $389.15M | $13.41 | -5.36% | -$59.03M | -4.18x | 1.60 | United States | ||
| SSSS | SURO CAPITAL CORP | NASDAQ | Asset Management | $256.67M | $10.11 | -1.56% | $53.71M | 5.03x | 0.34 | United States | ||
| SBGI | SINCLAIR INC | NASDAQ | Entertainment | $991.92M | $13.85 | -0.93% | $333.00M | -8.60x | 12.59 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.